Our lab studies the neurobiology underlying autism and other orphan developmental brain diseases. We are particularly interested in how cellular signaling among neurons is changed in patients with autism. We are also developing ways to identify treatments for this disease.
Ricardo is taking a leave of absence from Stanford. He is currently the Global Head of Neuroscience at the Novartis Institutes for BioMedical Research, a innovative center for biomedical research. NIBR is focused on discovering drugs that will change the practice of medicine. They have recruited Ricardo to develop an innovative approach to drug discovery for neuroscience, focusing on patient-centered research.
Ricardo will be supervising a streamlined group of projects at his laboratory at Stanford and will continue his strong collaborations with the doctors and researchers there. Patients and parents are encouraged to contact Dr. Joachim Hallmayer or Dr. Jon Bernstein at Stanford if they are interested in making tissue donations that will help researchers understand the molecular causes of neurodevelopment disorders, and develop cures for these disorders.
The goal of Ricardo's research at Stanford is to develop therapies and cures for children with neurological challenges. He is committed to advancing this goal in his new position at NIBR.
Ricardo Dolmetsch Ph.D.
Department of Neurobiology
Fairchild Research Laboratories Rm. D227
299 Campus Drive, Stanford CA 94305